PTC Therapeutics Competitors and Similar CompaniesClear all
PTC Therapeutics's competitors and similar companies include ReCode Therapeutics and Ipsen.
 PTC Therapeutics PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs. |  ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. | ||
Founding Date | Founding Date 1998 | Founding Date 2015 | Founding Date 1929 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations South Plainfield, US HQ | Locations Menlo Park, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more |
Employees | Employees 75448% increase | Employees 1062% decrease | Employees 5,358 |
Valuation ($) | Valuation ($) 3.3 b | Valuation ($) N/A | Valuation ($) 10.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) $1.7b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) |
Net income | Net income $682.6m (FY, 2025) | Net income N/A | Net income €445.1m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
ReCode Therapeutics
HQ
Menlo Park, US
Employees
106↓ 2% decrease
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
View company